Impact Factor
4.08
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.61
1,216 total citations
h5-index
46
h5 depth signal
Cited share
86.3%
202 of 234
Total citations
1,216
Citation footprint
Metric signal
5.88
External metric anchor
Self-citation
0.3%
4 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
467
China
343
Germany
109
Japan
57
Australia
44
Citing Fields of Research
Cancer & Development
376
Oncology
343
Immunology
220
Cancer, Autophagy & Apoptosis
209
Breast Cancer
131
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,909
Articles tracked across the journal lifetime
Indexed publication set
234
202 cited publications
Last 12 months
128
10.7 publications/month
Open access share
96.9%
124 OA publications in the last year
Leading citing country
United States
467 citing publications
Leading citing field
Cancer & Development
376 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Apr. 1999-
v1n1, Apr. 1999-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Cancer & Development
Oncology
Cancer, Autophagy & Apoptosis
Breast Cancer
Prostate Cancer
Broad Categories
Neoplasms
Cancer, Autophagy & Apoptosis
Immunology
Cancer & Development
Lung Cancer
Immunotherapy
Prostate Cancer
MeSH Descriptors
Neoplasms
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
04
05
DOI 10.1016/j.neo.2026.101380
Open DOI
Tumor-specific super-enhancer drives overexpression of EVI1/MECOM in ovarian cancer
06
07
DOI 10.1016/j.neo.2026.101379
Open DOI
An intron retention-derived secreted Endoglin Isoform as a circulating biomarker in pancreatic ductal adenocarcinoma
08
09
DOI 10.1016/j.neo.2026.101374
Open DOI
RSPO1–LGR4 axis drives cervical cancer progression via activation of the EGFR/Src/ERK/AKT signaling pathway
10
DOI 10.1016/j.neo.2026.101369
Open DOI
Senescence-associated prostate cancer cells promote fibroblast reprogramming and extracellular matrix remodeling
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 7, no. 12 (Dec. 2005)
Also issued online.
v. 1, no. 1 (April 20, 1999)20000717 Notice not published Printed on acid-free paper